PubRank

Karen Green

Author PubWeight™ 63.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003 14.29
2 An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 2002 3.39
3 Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 2005 2.59
4 Molecular complexity of successive bacterial epidemics deconvoluted by comparative pathogenomics. Proc Natl Acad Sci U S A 2010 2.43
5 Electrical propagation in synthetic ventricular myocyte strands from germline connexin43 knockout mice. Circ Res 2004 2.25
6 SARS among critical care nurses, Toronto. Emerg Infect Dis 2004 2.10
7 Relative contributions of connexins 40 and 43 to atrial impulse propagation in synthetic strands of neonatal and fetal murine cardiomyocytes. Circ Res 2006 1.97
8 Severe group a streptococcal soft-tissue infections in Ontario: 1992-1996. Clin Infect Dis 2002 1.93
9 Illness in intensive care staff after brief exposure to severe acute respiratory syndrome. Emerg Infect Dis 2003 1.76
10 Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. Gastroenterology 2005 1.73
11 Modeling transmission of methicillin-resistant Staphylococcus aureus among patients admitted to a hospital. Infect Control Hosp Epidemiol 2005 1.61
12 Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae. BMC Genomics 2009 1.47
13 Possible SARS coronavirus transmission during cardiopulmonary resuscitation. Emerg Infect Dis 2004 1.45
14 Self-collected mid-turbinate swabs for the detection of respiratory viruses in adults with acute respiratory illnesses. PLoS One 2011 1.33
15 In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002. Antimicrob Agents Chemother 2004 1.30
16 Effect of hard-drug use on CD4 cell percentage, HIV RNA level, and progression to AIDS-defining class C events among HIV-infected women. J Acquir Immune Defic Syndr 2004 1.22
17 Insulin pump therapy: guidelines for successful outcomes. Diabetes Educ 2009 1.18
18 Effect of patterns of transferring patients among healthcare institutions on rates of nosocomial methicillin-resistant Staphylococcus aureus transmission: a Monte Carlo simulation. Infect Control Hosp Epidemiol 2011 1.17
19 Focus group study of hand hygiene practice among healthcare workers in a teaching hospital in Toronto, Canada. Infect Control Hosp Epidemiol 2010 1.11
20 Dramatic accumulation of triglycerides and precipitation of cardiac hemodynamic dysfunction during brief caloric restriction in transgenic myocardium expressing human calcium-independent phospholipase A2gamma. J Biol Chem 2007 1.05
21 Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, Canada. PLoS One 2010 1.01
22 Risk factors for Kaposi's sarcoma-associated herpesvirus infection among HIV-1-infected pregnant women in the USA. AIDS 2003 1.00
23 JunD is a profibrogenic transcription factor regulated by Jun N-terminal kinase-independent phosphorylation. Hepatology 2006 1.00
24 Population-based surveillance for invasive pneumococcal disease in homeless adults in Toronto. PLoS One 2009 0.96
25 Susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Antimicrob Agents Chemother 2011 0.94
26 Patterns of handwashing behavior and visits to patients on a general medical ward of healthcare workers. Infect Control Hosp Epidemiol 2004 0.94
27 Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011. Vaccine 2013 0.91
28 When should a diagnosis of influenza be considered in adults requiring intensive care unit admission? Results of population-based active surveillance in Toronto. Crit Care 2011 0.91
29 In vitro activity of ceftaroline, ceftobiprole and cethromycin against clinical isolates of Streptococcus pneumoniae collected from across Canada between 2003 and 2008. J Antimicrob Chemother 2009 0.86
30 Have changing pneumococcal vaccination programmes impacted disease in Ontario? Vaccine 2013 0.86
31 Cluster of cases of severe acute respiratory syndrome among Toronto healthcare workers after implementation of infection control precautions: a case series. Infect Control Hosp Epidemiol 2006 0.86
32 Predicting patient discharge disposition after total joint arthroplasty in the United States. J Arthroplasty 2009 0.86
33 Characterization of the quinolone resistant determining regions in clinical isolates of pneumococci collected in Canada. Ann Clin Microbiol Antimicrob 2010 0.86
34 Prevalence and characterization of invasive isolates of Streptococcus pyogenes with reduced susceptibility to fluoroquinolones. Antimicrob Agents Chemother 2005 0.85
35 Respiratory syncytial virus infection-associated hospitalization in adults: a retrospective cohort study. BMC Infect Dis 2014 0.84
36 Infection control and antimicrobial restriction practices for antimicrobial-resistant organisms in Canadian tertiary care hospitals. Am J Infect Control 2007 0.84
37 Usp14 deficiency increases tau phosphorylation without altering tau degradation or causing tau-dependent deficits. PLoS One 2012 0.83
38 Impact of a mandatory infection control education program on nosocomial acquisition of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2009 0.78
39 Corticosteroid therapy in critical illness due to seasonal and pandemic influenza. Can Respir J 2015 0.75
40 Adverse effects of amantadine and oseltamivir used during respiratory outbreaks in a center for developmentally disabled adults. Infect Control Hosp Epidemiol 2004 0.75
41 Perceiving classroom aggression: the influence of setting, intervention style and group perceptions. Br J Educ Psychol 2005 0.75